^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Zinbryta (daclizumab)

    i
    Associations
    News
    Trials
    Company:
    AbbVie, Biogen
    Drug class:
    CD25 inhibitor, IL-2R antagonist
    Related drugs:
    Associations
    News
    Trials